GlassScriptPhysician profile
Brittney R Terry
NPI 1083870539
$2,365.08
in general payments reported to CMS, 2019-2025
19 companies · $583 in 2025
The $583 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $158 · 2021: $302 · 2022: $287 · 2023: $340 · 2024: $440 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $610.18 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $512.98 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $213.06 | 2019-2023 | Pediarix, Bexsero, Rotarix |
| Ironshore Pharmaceuticals INC. | $204.79 | 2020-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $169.88 | 2025 | Jornay Pm |
| Pfizer INC. | $154.46 | 2019-2025 | |
| Tris Pharma INC | $97.99 | 2019-2023 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $97.90 | 2020-2022 | |
| Sobi, INC | $84.01 | 2019 | |
| Merck Sharp & Dohme LLC | $40.42 | 2021-2024 | Gardasil, Vaxelis, Gardasil 9 |
| Abbvie INC. | $32.57 | 2020-2023 | Lupron Depot |
| Ucb, INC. | $30.80 | 2021 | |
| Mayne Pharma Commercial LLC | $22.03 | 2023-2025 | |
| Sanofi Pasteur INC. | $19.14 | 2025 | |
| Genentech USA, INC. | $16.67 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $16.40 | 2022 | |
| Advanced Respiratory, INC | $16.15 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $14.00 | 2025 | Neffy |
| Shire North American Group INC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Terry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.